1Nelson NJ.Inhibitors of angiogenesis enter phase Ⅲ testign[].Journal of the National Cancer Institute.1998
2Dalmay T,Hamilton A,Rudd S,et al.An RNA-dependent RNA polymerase gene in arabidopsis is required for post-transcriptional gene silencing mediated by a transgene but not by a virus[].Cell.2000
3Zamore PD.RNA interference: listening to the sound of silence[].Natural Structural Biology.2001
4Lu D,Jimenez X,Zhang H,et al.Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy[].International Journal of Cancer.2002
5Pavco PA,Bouhana KS,Gallegos AM,et al.Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors[].Clinical Cancer Research.2000
6Brummelkamp TR,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells[].Science.2002
7Elbashir SM,Harborth J,Lendeckel W,et al.Tuschl.2001. Duplexes of 212nucleotide RNAs mediate RNA interference in cultured mammalian cells[].Nature.2001
8Kamiyama M,Ichikawa Y,Ishikawa T,et al.VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice[].Cancer Gene Therapy.2002
9Yuan A,Yu CJ. Kuo SH,et al.Vascularendothelial growth factor189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-smallcell lung cancer[].Journal of Clinical Oncology.2001
10Ng Y S,Rohan R,Sunday ME,Demello DE,Amore PAD.Differential expression of VEGF isoforms in mouse during development and in the adult[].Developmental Dynamics.2001
3Poon RT,Fan ST,Wong J.Clinical implications of circulating angiogenic factors in cancer patients.J Clin Oncol.2001,19(4):1207.
4Kraft A,Weindel K,Ochs A,et al.Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.Cancer.1999,85(1):178.
5Saito M,Satoh S,Tsuchiya N,et al.Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma.Jpn J Cancer Res.1999,90(8):874.
6Mitsuhashi A,Suzuka K,Yamazawa K,et al.Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.Cancer.2005,103(4):724.
7Beecken WD,Engl T,Hofmann J,et al.Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder.J Cell Mol Med.2005,9(3):655.
8Shimanuki Y,Takahashi K,Cui R,et al.Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.Lung.2005,183(1):29.
9Karayiannakis AJ,Bolanaki H,Syrigos KN,et al.Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis.Cancer Lett.2003,194(1):119.
10Kimura H,Liu S,Yamada S,et al.Rapid increase in serum lipid peroxide 4-hydroxynonenal (HNE) through monocyte NADPH oxidase in early endo-toxemia.Free Radic Res.2005,39(8):845.
